| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Merck & Co., Inc. (MRK) has 26 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. MRK is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 456.9K | $54.39M | - | |
| VP | 197.9K | $23.56M | - | |
| Dir | 110.9K | $13.20M | - | |
| Pres | 96.8K | $11.52M | - | |
| CFO | 94.2K | $11.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2018 | Weeks Wendell P62 | Director | Sale+OE | 5,000 | $53.57 | $267,833.00 | -98.0% | |
| Jan 16, 2018 | Schechter Adam H | EVP &Pres-global Human Health | Sale+OE | 101,602 | $61.63 | $6,261,731.26 | -61.8% | |
| Jan 16, 2018 | Holston Michael J | EVP, General Counsel | Sell | 12,500 | $61.63 | $770,375.00 | -20.3% | |
| Jan 16, 2018 | Graddick Weir Mirian M | Exe V-p, Hr | Sale+OE | 65,000 | $61.35 | $3,987,800.00 | -16.0% | |
| Nov 8, 2017 | Glocer Thomas H | Director | Sale+OE | 5,000 | $56.20 | $280,982.50 | -49.5% | |
| May 12, 2017 | Kidder C Robert | Director | Sale+OE | 5,000 | $63.54 | $317,695.00 | -34.9% | |
| Apr 3, 2017 | Schechter Adam H | EVP &Pres-global Human Health | Sell | 53,850 | $63.48 | $3,418,166.45 | -31.6% | |
| Feb 14, 2017 | Karachun Rita A | Sr. VP Fince-global Controller | Sell | 2,954 | $64.73 | $191,226.60 | -20.2% | |
| Feb 8, 2017 | Russo Patricia F | Director | Sale+OE | 5,000 | $64.42 | $322,121.00 | -27.6% | |
| Feb 6, 2017 | Weeks Wendell P62 | Director | Sale+OE | 5,000 | $64.51 | $322,541.50 | -98.0% |